Medical Health & Life Science Research News

Recent research: Pediatric vaccine market analysis and forecasts, from 2014 to 2024

Medical Market Research

Vaccination is a process or technique of improving the immunity of an individual against any specific infectious or chronic disease.

So far, vaccination has saved a large number of lives including children, adults and animals, thus furnishing them with a relatively better and healthier quality of life saving and immunizing them against various infectious microorganisms such as bacteria and virus.

This is considered to be one of the most crucial reasons behind the rapid growth of global pediatrics vaccines market over the forecast period. In addition, vaccines are able to stimulate the immune systems of human body in order to protect the concerned individual from subsequent diseases or infections.

Vaccines are usually categorized into two main target markets such as pediatric and adult. Pediatric vaccines thus are most commonly employed for proper and efficient immunization of toddlers and children as well as adolescents against several infections such as diphtheria, diseases, hepatitis, influenza, meningococcal diseases and pneumococcal diseases among others.

Download Table of Content and Sample Copy @…le-of-content/362 Make an Inquiry about this news

Rising non-government and government funding associated with the development of vaccines is one of the key factors driving the overall pediatric vaccine market over the forecast period. In addition, advancements in technology such as therapeutic and adjuvant vaccines are further anticipated to fuel the growth of global pediatric vaccines market over the forecast period.

Additionally, increasing investments by various players in the market as well as key manufacturers of pediatric vaccines is further increasing the growth of global market. Moreover, increasing inclination of organizations as well as government bodies on immunization schedule prescribed by doctors for the adolescents as well as rising awareness programs led by healthcare organizations such as WHO, UNICEF and others are further projected to bolster the growth of global pediatric vaccines market.

Request Report @…customization/362 Make an Inquiry about this news

The global pediatric vaccines market can be segmented on the basis of technology, diseases and region. On the basis of technology, the global pediatric vaccines market can be segmented into live attenuated vaccines, recombinant vaccines, inactivated and subunit vaccines, conjugate vaccines, toxoid vaccines.

On the basis of diseases, the global pediatric vaccines market can be segmented into diphtheria, hepatitis B, hepatitis A, measles, mumps, polio, rubella, tetanus, varicella, pertussis, influenza and others. On the basis of region, the global pediatric vaccines market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

The robust demand in Asia-Pacific is expected to be the major driving factor for the growth of pediatrics vaccines market. China is anticipated to account for the largest share and lead the overall demand for pediatrics vaccines owing to the increasing industrial production over the last few years.

The markets in other developing countries such as Brazil, Russia, Poland, Indonesia, New Zealand, Argentina and India among others are also anticipated to grow rapidly throughout the forecast period.

Major players operating in the global pediatrics vaccines market are focusing on some key market strategies such as mergers and acquisitions to keep hold in the ever competitive market. Moreover, they are concentrating on collaborating with local players to increase their market reach as well as strengthen their goodwill in the global market.

Some of the major players in global pediatrics vaccines system market include Sanofi, Novartis AG., Amgen Inc., Abbott Laboratories, AstraZeneca Plc, Shire Pharmaceuticals Group Plc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Merck & Co. Inc, Eli Lilly and Company, GlaxoSmithKline, Genentech Inc., Shire Pharmaceuticals Group Plc, Actelion Pharmaceuticals Ltd, Shire Pharmaceuticals Group Plc and Abbott Laboratories among others.

Make an inquiry for this report @…before-buying/362 Make an Inquiry about this news

Market Segmentation

Market by Technology

Live Attenuated Vaccines

Recombinant Vaccines

Inactivated and Subunit Vaccines

Conjugate Vaccines

Toxoid Vaccines

Market by Disease


Hepatitis B

Hepatitis A




Others (Tetanus, Varicella, Pertussis, Rubella, Mumps,.)

Market by Geography

North America

o US

o Canada

o Mexico


o UK

o Germany

o France

o Rest of Europe


o China

o Japan

o India

o Philippines

o Rest of Asia-Pacific

Latin America

o Brazil

o Chile

o Rest of Latin America

Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o Rest of MEA

Access this premium research report @ Make an Inquiry about this news

News From

Acumen Research and ConsultingAcumen Research and Consulting
Category: Market Research Publishers and RetailersCompany about: Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!